Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.

scientific article published on 25 October 2013

Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00280-013-2319-2
P698PubMed publication ID24158402

P2093author name stringHua Song
Xue-ying Chen
Bin-hua Pan
Jun-qing Mao
Ling-yan Zhang
Wei-qun Xu
Yong-min Tang
Jing-yuang Li
P2860cites workPopulation pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration dataQ33399245
Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancerQ34780653
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustmentsQ37034349
Recent research advances in childhood acute lymphoblastic leukemiaQ37815272
Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing countryQ37978262
Long-term outcome of childhood acute lymphoblastic leukemia treated in ChinaQ39847866
Influence of high‐dose methotrexate therapy (HD‐MTX) on glomerular and tubular kidney functionQ44401633
High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearanceQ44916270
Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in ChinaQ46961911
Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression AnalysisQ57618557
P433issue1
P921main subjectmethotrexateQ422232
P304page(s)79-86
P577publication date2013-10-25
P1433published inCancer Chemotherapy and PharmacologyQ326137
P1476titleSerum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
P478volume73

Reverse relations

cites work (P2860)
Q88626086Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate
Q37088471New approaches in primary central nervous system lymphoma
Q37496637Preventing and Managing Toxicities of High-Dose Methotrexate
Q39185721Primary central nervous system lymphoma: essential points in diagnosis and management
Q47772751Purification and activity characterization of polysaccharides in the medicinal lichen Umbilicaria tornata from Taibai Mountain, China
Q33427484Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate
Q89782225Severe Oral Mucositis in Pediatric Cancer Patients: Survival Analysis and Predictive Factors
Q30397448What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?

Search more.